{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:18:50Z","timestamp":1762161530954,"version":"3.41.2"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T00:00:00Z","timestamp":1569542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.00966","type":"journal-article","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T08:40:14Z","timestamp":1569573614000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Effects of Dabigatran in Mouse Models of Aging and Cerebral Amyloid Angiopathy"],"prefix":"10.3389","volume":"10","author":[{"given":"Neethu","family":"Michael","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mher Mahoney","family":"Grigoryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelley","family":"Kilday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachita K.","family":"Sumbria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitaly","family":"Vasilevko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"van Ryn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Cribbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annlia","family":"Paganini-Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,9,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have non-valvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fneur.2013.00137","article-title":"MRI screening for chronic anticoagulation in atrial fibrillation","volume":"4","author":"Fisher","year":"2013","journal-title":"Front Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e010133","DOI":"10.1161\/JAHA.118.010133","article-title":"Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: time to initiation of oral anticoagulant therapy and outcomes","volume":"7","author":"Paciaroni","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"B4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1160\/TH07-03-0183","article-title":"In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate","volume":"98","author":"Wienen","year":"2007","journal-title":"Thromb Haemost"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1021\/jm0109513","article-title":"Structure-based design of novel potent non-peptide thrombin inhibitors","volume":"45","author":"Hauel","year":"2002","journal-title":"J Med Chem"},{"key":"B6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jneuroim.2016.05.018","article-title":"Differential effects on glial activation by a direct versus an indirect thrombin inhibitor","volume":"297","author":"Marangoni","year":"2016","journal-title":"J Neuroimmunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2165\/00003088-200847050-00001","article-title":"Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate","volume":"47","author":"Stangier","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2165\/11206400-000000000-00000","article-title":"Dabigatran etexilate: a review of its use in the prevention of stroke and systemic embolism in patients with atrial fibrillation","volume":"11","author":"Garnock-Jones","year":"2011","journal-title":"Am J Cardiovasc Drugs"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1046\/j.1471-4159.2000.0751539.x","article-title":"Thrombin-induced activation of cultured rodent microglia","volume":"75","author":"Moller","year":"2000","journal-title":"J Neurochem"},{"key":"B10","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/nrn1255","article-title":"Proteinase-activated receptors in the nervous system","volume":"4","author":"Noorbakhsh","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jns.2008.03.010","article-title":"The expression and the role of protease nexin-1 on brain edema after intracerebral hemorrhage","volume":"270","author":"Wu","year":"2008","journal-title":"J Neurol Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.neuint.2010.06.002","article-title":"Time course of upregulation of inflammatory mediators in the hemorrhagic brain in rats: correlation with brain edema","volume":"57","author":"Wu","year":"2010","journal-title":"Neurochem Int"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1111\/j.1538-7836.2005.01377.x","article-title":"Protease-activated receptors in hemostasis, thrombosis and vascular biology","volume":"3","author":"Coughlin","year":"2005","journal-title":"J Thromb Haemost"},{"key":"B14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/00043426-200005000-00019","article-title":"Hemostatic factors in tumor biology","volume":"22","author":"Palumbo","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1161\/STROKEAHA.110.593657","article-title":"Cerebral microbleeds in the elderly: a pathological analysis","volume":"41","author":"Fisher","year":"2010","journal-title":"Stroke"},{"key":"B16","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.3171\/2012.1.FOCUS11370","article-title":"Cerebral amyloid angiopathy-associated intracerebral hemorrhage: pathology and management","volume":"32","author":"Mehndiratta","year":"2012","journal-title":"Neurosurg Focus"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/j.jocn.2015.04.020","article-title":"The role of age in intracerebral hemorrhages","volume":"22","author":"Camacho","year":"2015","journal-title":"J Clin Neurosci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1161\/STROKEAHA.114.007953","article-title":"Influence of intracerebral hemorrhage location on incidence, characteristics, and outcome: population-based study","volume":"46","author":"Samarasekera","year":"2015","journal-title":"Stroke"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1161\/STROKEAHA.116.013323","article-title":"Managing risk after intracerebral hemorrhage in concomitant atrial fibrillation and cerebral amyloid angiopathy","volume":"47","author":"Stoker","year":"2016","journal-title":"Stroke"},{"key":"B20","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1161\/STROKEAHA.117.016990","article-title":"Diagnosis of cerebral amyloid angiopathy","volume":"49","author":"Greenberg","year":"2018","journal-title":"Evol Boston Criteria"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1161\/STROKEAHA.115.009324","article-title":"Cerebral microbleeds predict intracerebral hemorrhage in hemodialysis patients","volume":"46","author":"Naganuma","year":"2015","journal-title":"Stroke"},{"key":"B22","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1161\/STROKEAHA.115.011843","article-title":"Incident cerebral microbleeds in a cohort of intracerebral hemorrhage","volume":"47","author":"Pasquini","year":"2016","journal-title":"Stroke"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s00415-016-8339-1","article-title":"The impact of cerebral microbleeds on intracerebral hemorrhage and poor functional outcome of acute ischemic stroke patients treated with intravenous thrombolysis: a systematic review and meta-analysis","volume":"264","author":"Wang","year":"2017","journal-title":"J Neurol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1523\/JNEUROSCI.21-02-00372.2001","article-title":"Age-dependent changes in brain, CSF, and plasma amyloid \u03b2 protein in the Tg2576 transgenic mouse model of alzheimer's disease","volume":"21","author":"Kawarabayashi","year":"2001","journal-title":"J Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1161\/STROKEAHA.111.626655","article-title":"Therapeutic modulation of cerebral microhemorrhage in a mouse model of cerebral amyloid angiopathy","volume":"42","author":"Fisher","year":"2011","journal-title":"Stroke"},{"key":"B26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"key":"B27","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/01.jnen.0000171644.00180.fc","article-title":"Progression of cerebral amyloid angiopathy in transgenic mouse models of Alzheimer Disease","volume":"64","author":"Domnitz","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1161\/STROKEAHA.114.006078","article-title":"Cerebral amyloid angiopathy increases susceptibility to infarction after focal cerebral ischemia in Tg2576 mice","volume":"45","author":"Milner","year":"2014","journal-title":"Stroke"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.4161\/cbt.10.10.13236","article-title":"Use of dabigatran etexilate to reduce breast cancer progression","volume":"10","author":"DeFeo","year":"2010","journal-title":"Cancer Biol Therapy"},{"key":"B30","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1369\/0022155414546692","article-title":"Comparative analysis of H&E and Prussian blue staining in a mouse model of cerebral microbleeds","volume":"62","author":"Liu","year":"2014","journal-title":"J Histochem Cytochem"},{"key":"B31","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/jcbfm.2015.9","article-title":"Dabigatran abrogates brain endothelial cell permeability in response to thrombin","volume":"35","author":"Hawkins","year":"2015","journal-title":"J Cerebral Blood Flow Metabol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1161\/STROKEAHA.117.017994","article-title":"Cerebral microbleeds in murine amyloid angiopathy: natural course and anticoagulant effects","volume":"48","author":"Marinescu","year":"2017","journal-title":"Stroke"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1212\/WNL.0000000000000871","article-title":"Cerebral microbleeds: where are we now?","volume":"83","author":"Fisher","year":"2014","journal-title":"Neurology"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00966\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T08:40:16Z","timestamp":1569573616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00966\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,27]]},"references-count":33,"alternative-id":["10.3389\/fneur.2019.00966"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.00966","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2019,9,27]]},"article-number":"966"}}